Equities

Creo Medical Group PLC

CREO:LSE

Creo Medical Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)35.50
  • Today's Change0.20 / 0.57%
  • Shares traded557.10k
  • 1 Year change44.90%
  • Beta1.1791
Data delayed at least 20 minutes, as of May 20 2024 11:43 BST.
More ▼

Profile data is unavailable for this security.

About the company

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

  • Revenue in GBP (TTM)30.80m
  • Net income in GBP-21.70m
  • Incorporated2016
  • Employees279.00
  • Location
    Creo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
  • Phone+44 12 9160 6005
  • Websitehttps://creomedical.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Belluscura PLC946.97k-7.88m28.39m24.0028.39m24.00
SDI Group PLC68.07m1.61m66.49m489.0066.49m489.00
Inspecs Group PLC203.29m-997.00k74.73m1.67k74.73m1.67k
Creo Medical Group PLC30.80m-21.70m127.60m279.00127.60m279.00
Tristel Plc39.49m6.04m209.16m213.00209.16m213.00
Avon Protection PLC191.98m-12.91m391.73m928.00391.73m928.00
Advanced Medical Solutions Group plc126.21m15.89m457.65m850.00457.65m850.00
Data as of May 20 2024. Currency figures normalised to Creo Medical Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

37.83%Per cent of shares held by top holders
HolderShares% Held
Canaccord Genuity Wealth Ltd.as of 19 Mar 202439.30m10.87%
M&G Investment Management Ltd.as of 31 Jan 202433.53m9.28%
Amati Global Investors Ltd.as of 31 Jan 202415.71m4.35%
Baillie Gifford & Co.as of 31 Dec 202212.54m3.47%
SVM Asset Management Ltd.as of 30 Jun 202310.62m2.94%
AXA Investment Managers UK Ltd.as of 31 Dec 20227.99m2.21%
Chelverton Asset Management Ltd.as of 30 Jun 20237.50m2.08%
Octopus Investments Ltd.as of 30 Apr 20243.70m1.02%
Border to Coast Pensions Partnership Ltd.as of 30 Sep 20233.36m0.93%
BlackRock Investment Management (UK) Ltd.as of 30 Sep 20232.49m0.69%
More ▼
Data from 30 Sep 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.